Related Experiment Video
Updated: Aug 27, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Myoglobin and left ventricular ejection fraction as predictive markers for death in children with fulminant
Tingting Xie1, Xiaodong Zang2, Yingying Xiong2
1Department of Pediatrics, Provincial Hospital Affiliated to Anhui Medical University, Hefei, China.
Insights
Myoglobin (MYO) and left ventricular ejection fraction (LVEF) levels predict outcomes in children with fulminant myocarditis (FM). Combining MYO and LVEF improves prognostic accuracy for this severe pediatric heart condition.
Area of Science:
- Pediatric Cardiology
- Critical Care Medicine
- Biomarker Research
Background:
- Fulminant myocarditis (FM) is a severe pediatric heart condition causing rapid cardiac dysfunction and high mortality.
- Identifying prognostic factors is crucial for managing children with FM.
Purpose of the Study:
- To investigate clinical characteristics and prognostic factors in children diagnosed with FM.
- To determine predictors of in-hospital mortality in pediatric FM cases.
Main Methods:
- A cohort of 37 pediatric patients with FM was analyzed retrospectively.
- Multivariate logistic regression and ROC curve analysis identified predictors of mortality.
- Patients were categorized into survival (25) and death (12) groups.
Main Results:
- Children in the death group had higher levels of procalcitonin, creatine kinase, and myoglobin (MYO) compared to survivors.
- Left ventricular ejection fraction (LVEF) was significantly lower in the death group.
- MYO and LVEF were identified as independent predictors of mortality in pediatric FM, with combined detection showing higher predictive value.
Conclusions:
- Myoglobin (MYO) and left ventricular ejection fraction (LVEF) serve as valuable prognostic markers for fulminant myocarditis in children.
- The combined assessment of MYO and LVEF enhances the accuracy of disease severity evaluation and prognosis prediction.
- These biomarkers hold significant clinical utility for managing pediatric FM patients.
Background:
Fulminant myocarditis (FM) is an inflammatory process of the myocardium and an important cause of cardiac dysfunction in children; it is characterized by rapid onset, acute progression, and high mortality. The study sought to describe the clinical characteristics and prognostic factors in children with FM.
Methods:
The study population consists of 37 consecutive patients admitted from May 2014 to December 2021 with a diagnosis of FM. According to the prognosis of children with FM during hospitalization, they were divided into "survival" group (25 cases) and "death" group (12 cases). A multivariate logistic regression analysis was performed to identify the independent predictors of in-hospital mortality in the patients, and receiver operating characteristic (ROC) curve was used to explore the predictive value of related factors.
Results:
The 37 children with FM had an average age of 8.35 ± 4.36 years old. Twenty-five of the patients survived and 12 died. Twenty-five of the children were discharged from the hospital after a series of active rescue treatments such as nutritional myocardial drugs, high-dose intravenous immunoglobulin (IVIG), glucocorticoids (GCs), temporary pacemaker (TP), extracorporeal membrane oxygenation (ECMO), and continuous renal replacement therapy (CRRT).Twelve of the children were classified into the death group because the resuscitation failed. The levels of procalcitonin (PCT), creatine kinase (CK), and myoglobin (MYO) in the death group were all higher than in the survival group (all P < 0.05), and the left ventricular ejection fraction (LVEF) in the death group was significantly lower than in the survival group (P = 0.002). The binary logistic regression analysis revealed that MYO [OR:1.006; 95%CI:(1-1.012); P = 0.045] and LVEF [OR: 0.876; 95% CI: (0.785-0.978); P = 0.019] were independent predictors of FM. ROC curve analysis showed that the area under ROC curve (AUC) of MYO and LVEF was [AUC:0.957; 95%CI:0.897~1] and [AUC:0.836; 95%CI:0.668~1], and the area under the combined ROC curve for MYO + LVEF was significantly higher than that for MYO or LVEF alone (P < 0.05), indicating that the MYO + LVEF combined diagnosis had a higher predictive value for FM.
Conclusion:
The levels of MYO and LVEF can be markers for prognosis of FM and can effectively evaluate the disease severity. Their combination can improve forecast accuracy; thus, the detection of the above-mentioned indexes possesses a higher value for clinical applications.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

